Prevalidation study of the BALB/c 3T3 cell transformation assay for assessment of carcinogenic potential of chemicals. 2012

Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
Hatano Research Institute, Food and Drug Safety Center, Kanagawa, Japan. tanaka.n@fdsc.or.jp

The cell transformation assays (CTAs) have attracted attention within the field of alternative methods due to their potential to reduce the number of animal experiments in the field of carcinogenicity. The CTA using BALB/c 3T3 cells has proved to be able to respond to chemical carcinogens by inducing morphologically transformed foci. Although a considerable amount of data on the performance of the assay has been collected, a formal evaluation focusing particularly on reproducibility, and a standardised protocol were considered important. Therefore the European Centre for the Validation of Alternative Methods (ECVAM) decided to coordinate a prevalidation study of the BALB/c 3T3 CTA. Three different laboratories from Japan and Europe participated. In the study the following modules were assessed stepwise: test definition (Module 1) consisted of the standardisation of the protocol, the selection of the cell lineage, and the preparation of a photo catalogue on the transformed foci. The within-laboratory reproducibility (Module 2) and the transferability (Module 3) were assessed using non-coded and coded 3-methylcholanthrene. Then, five coded chemicals were tested for the assessment of between-laboratory reproducibility (Module 4). All three laboratories obtained positive results with benzo[a]pyrene, phenanthrene and o-toluidine HCl. 2-Acetylaminofluorene was positive in two laboratories and equivocal in one laboratory. Anthracene was negative in all three laboratories. The chemicals except phenanthrene, which is classified by IARC (http://monographs.iarc.fr) as group 3 "not classifiable as to its carcinogenicity to human", were correctly predicted as carcinogens. Further studies on phenanthrene will clarify this discrepancy. Thus, although only a few chemicals were tested, it can be seen that the predictive capacity of the BALB/c 3T3 CTA is satisfactory. On the basis of the outcome of this study, an improved protocol, incorporating some changes related to data interpretation, has been developed. It is recommended that this protocol be used in the future to provide more data that may confirm the robustness of this protocol and the performance of the assay itself. During the study it became clear that selecting the most appropriate concentrations for the transformation assay is crucial.

UI MeSH Term Description Entries
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000826 Animal Testing Alternatives Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories. Alternatives to Animal Testing,Alternative, Animal Testing,Alternatives, Animal Testing,Animal Testing Alternative,Testing Alternative, Animal,Testing Alternatives, Animal
D015197 Carcinogenicity Tests Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. Tumorigenicity Tests,Carcinogen Tests,Carcinogenesis Tests,Carcinogenic Activity Tests,Carcinogenic Potency Tests,Carcinogen Test,Carcinogenesis Test,Carcinogenic Activity Test,Carcinogenic Potency Test,Carcinogenicity Test,Potency Test, Carcinogenic,Potency Tests, Carcinogenic,Test, Carcinogen,Test, Carcinogenesis,Test, Carcinogenic Activity,Test, Carcinogenic Potency,Test, Carcinogenicity,Test, Tumorigenicity,Tests, Carcinogen,Tests, Carcinogenesis,Tests, Carcinogenic Activity,Tests, Carcinogenic Potency,Tests, Carcinogenicity,Tests, Tumorigenicity,Tumorigenicity Test
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D054928 Validation Studies as Topic Works on research using processes by which the reliability and relevance of a procedure for a specific purpose are established.
D041702 BALB 3T3 Cells Cell lines developed from disaggregated BALB/c mouse embryos. They are extremely sensitive to CONTACT INHIBITION, and highly susceptible to transformation by SV40 VIRUS and murine sarcoma virus (SARCOMA VIRUSES, MURINE). 3T3 Cells, BALB,BALB 3T3 clone A31,BALB-3T3 Cells,BALB-c 3T3 Cells,3T3 Cell, BALB,3T3 Cell, BALB-c,3T3 Cells, BALB-c,BALB 3T3 Cell,BALB c 3T3 Cells,BALB-3T3 Cell,BALB-c 3T3 Cell,Cell, BALB 3T3,Cell, BALB-3T3,Cell, BALB-c 3T3,Cells, BALB 3T3,Cells, BALB-3T3,Cells, BALB-c 3T3

Related Publications

Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
June 2010, Toxicology in vitro : an international journal published in association with BIBRA,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
May 2016, Environmental toxicology,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
April 2012, Mutation research,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
April 2012, Mutation research,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
January 1999, IARC scientific publications,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
October 2012, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
April 2004, Toxicology in vitro : an international journal published in association with BIBRA,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
April 2009, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
September 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Noriho Tanaka, and Susanne Bohnenberger, and Thorsten Kunkelmann, and Barbara Munaro, and Jessica Ponti, and Albrecht Poth, and Enrico Sabbioni, and Ayako Sakai, and Susan Salovaara, and Kiyoshi Sasaki, and B Claire Thomas, and Makoto Umeda
April 2012, Mutation research,
Copied contents to your clipboard!